Digital thermometer Automatic blood pressure monitors
Fertility
Testing - whenever and wherever necessary
Pregnancy (hCG): Pregnancy test yields yes/no results. A qualitative urine or blood hCG test is ordered as early as 10 days after a missed menstrual period if a woman wishes to confirm whether or not she is pregnant (some methods can detect hCG even earlier, at one week after conception). In certain patients, several quantitative blood hCG tests over several days may be ordered to rule out an ectopic pregnancy or to monitor a woman after a miscarriage.
Ovulation (LH): Diagnosis of ovulation by detecting the hormone LH. LH is often used in conjunction with other tests (FSH, testosterone, estradiol and progesterone) in the workup of infertility in both men and women. LH levels are also useful in the investigation of menstrual irregularities and to aid in the diagnosis of pituitary disorders. In children, FSH and LH are used to diagnose delayed and precocious (early) puberty.
Menopause (FSH): Diagnosis of menopause in women. FSH test is often if you are having difficulty getting pregnant or are having irregular menstrual periods or if your doctor thinks that you have symptoms of a pituitary or hypothalamic disorder. This test evaluates your pituitary function, especially in terms of fertility issues.
Infectious Diseases
Testing - whenever and wherever necessary
HBsAg HBsAb HBeAb
HBeAg HBcAb
HCV HIV 1/2/O H pylori
Malaria Strep A Chlamydia Syphilis.
For more details please contact us to see our product catalog.
Drugs of Abuse
Testing - whenever and wherever necessary
AMP BAR BUP BZO COC MDMA MET MOP MTD OPI PCP THC TCA
For more details please contact us to see our product catalog.
Tumor Markers
Testing - whenever and wherever necessary
Alpha-fetoprotein test (AFP): The most widely used biochemical blood test for liver cancer. Generally, normal levels of AFP are below 10 ng/ml. Moderate levels of AFP (even almost up to 500 ng/ml) can be seen in patients with chronic hepatitis. An AFP greater than 500 ng/ml is very suggestive of hepatocellular carcinoma (HCC)
Carcinoembryonic Antigen test (CEA): The carcinoembryonic antigen (CEA) test measures the amount of a protein that may appear in the blood of some people who have certain kinds of cancers, especially large intestine (colon and rectal) cancer. It may also be present in people with cancer of the pancreas, breast, ovary, or lung.
Fecal occult blood test (FOB): Detects lower level of fecal occult blood as a method to diagnose gastric bleeding. This test uses a chemical process to check stool for hidden (occult) blood. The blood is often hidden in the sense that it may be passed in such small amounts that it can be detected only through chemical testing. Occult blood in stool may be a sign of cancer or polyps (growths) in the colon or rectum because these conditions sometimes cause bleeding. Other causes of intestinal bleeding include inflammatory bowel disease (such as colitis), ulcers and hemorrhoids.
Prostate Specific Antigen test (PSA): PSA is a substance produced by cells from the prostate. Under normal circumstances, PSA is secreted by the prostate into semen to help with reproduction by preventing the coagulation of semen. However, small amounts of PSA naturally leak out into the bloodstream as well. When prostate cancer is present, the prostate ducts that normally secrete PSA into the urethra get clogged and more PSA leaks out of the prostate into the bloodstream.
During the PSA test, a small amount of blood is drawn from the arm, and PSA levels are measured. PSA blood test results are reported as nanograms per milliliter (ng/ml). Results under 4 ng/ml are usually considered normal (however, some experts have recently argued that 2.5 ng/ml should be established as the upper limit of "normal"). Results over 10 ng/ml are high, and results between 4 and 10 are considered intermediate. The higher the PSA level, the more likely a patient has prostate cancer.
Cardiac Markers
Testing - whenever and wherever necessary
CKMB test: Diagnosis of acute myocardial infarction (AMI) for heart attack. Creatine kinase-MB isoenzyme is well documented as a marker for acute myocardial infarction (AMI). It is found in blood within 6 hours of myocardial necrosis, and peaks in 13-15 hours with a typical range of 39-185 ng/ml. Elevated levels persist for 2-3 days after the onset of chest pain.
Troponin I (Tni) test: Diagnosis of acute myocardial infarction (AMI) for heart attack. Troponin tests are primarily ordered for people who have chest pain to see if they have had a heart attack or other damage to their heart. Either a Troponin I or a Troponin T can be performed; usually a laboratory will offer one test or the other. The troponin test may be ordered by itself or along with other cardiac biomarkers, tests for substances such as CK, CK-MB, and myoglobin. Troponin I and troponin T tests have begun to replace CK and CK-MB tests because they are more specific for heart injury (versus skeletal muscle injury) and are elevated for a longer period of time, but many doctors still prefer to have the additional information they get by ordering more than one cardiac biomarker.
Myoglobin test: Diagnosis of acute myocardial infarction (AMI) for heart attack. Myoglobin diffuses rapidly throughout the vascular system and provides the earliest indication of AMI. Myoglobin levels become elevated 30 minutes to 2 hours after chest pain onset and peak within 5 to 12 hours. Myoglobin is the most extensively studied biomarker as an early indicator of myocardial necrosis for patients who present to the emergency department within 6 hours of the onset of symptoms.
CKMB/ Troponin I (Tni)/ Myoglobin test: A panel of test for acute myocardial infraction. This is a combo(three tests in one Cassette) test.
Blood Glucose Monitoring
Testing - whenever and wherever necessary
For more details please contact us to see our product catalog.
Urinalysis
Testing - whenever and wherever necessary
Urinalysis reagent strips Manuel urine analyzer
For more details please contact us to see our product catalog.
Ovulation (LH): Diagnosis of ovulation by detecting the hormone LH. LH is often used in conjunction with other tests (FSH, testosterone, estradiol and progesterone) in the workup of infertility in both men and women. LH levels are also useful in the investigation of menstrual irregularities and to aid in the diagnosis of pituitary disorders. In children, FSH and LH are used to diagnose delayed and precocious (early) puberty.
Menopause (FSH): Diagnosis of menopause in women. FSH test is often if you are having difficulty getting pregnant or are having irregular menstrual periods or if your doctor thinks that you have symptoms of a pituitary or hypothalamic disorder. This test evaluates your pituitary function, especially in terms of fertility issues.
HBeAg
Fecal occult blood test (FOB): Detects lower level of fecal occult blood as a method to diagnose gastric bleeding. This test uses a chemical process to check stool for hidden (occult) blood. The blood is often hidden in the sense that it may be passed in such small amounts that it can be detected only through chemical testing. Occult blood in stool may be a sign of cancer or polyps (growths) in the colon or rectum because these conditions sometimes cause bleeding. Other causes of intestinal bleeding include inflammatory bowel disease (such as colitis), ulcers and hemorrhoids.
Prostate Specific Antigen test (PSA): PSA is a substance produced by cells from the prostate. Under normal circumstances, PSA is secreted by the prostate into semen to help with reproduction by preventing the coagulation of semen. However, small amounts of PSA naturally leak out into the bloodstream as well. When prostate cancer is present, the prostate ducts that normally secrete PSA into the urethra get clogged and more PSA leaks out of the prostate into the bloodstream.
During the PSA test, a small amount of blood is drawn from the arm, and PSA levels are measured. PSA blood test results are reported as nanograms per milliliter (ng/ml). Results under 4 ng/ml are usually considered normal (however, some experts have recently argued that 2.5 ng/ml should be established as the upper limit of "normal"). Results over 10 ng/ml are high, and results between 4 and 10 are considered intermediate. The higher the PSA level, the more likely a patient has prostate cancer.